Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria · Delayed Price · Currency is NGN 11.20
+0.90 (8.74%)
At close: May 25, 2026
NGX:NEIMETH Cash Flow Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 |
Net Income | 974.05 | 976.42 | -885.33 | -1,798 | -325.04 | -109.66 |
Depreciation & Amortization | 181.37 | 164.91 | 129.99 | 126.09 | 115.96 | 119.57 |
Other Amortization | 9.5 | 9.5 | 9.5 | - | - | - |
Loss (Gain) From Sale of Assets | -1.5 | -1.2 | -3.6 | -0.97 | - | - |
Asset Writedown & Restructuring Costs | -697.3 | -697.3 | -923.66 | -1,068 | - | - |
Provision & Write-off of Bad Debts | -10 | - | - | - | 45.2 | 19.2 |
Other Operating Activities | 1,740 | 1,621 | 891.73 | 473.65 | 260.84 | 53.07 |
Change in Accounts Receivable | -130.18 | 273.83 | -772.25 | 547.8 | -137.71 | -6.92 |
Change in Inventory | -994.64 | -2,026 | 196.94 | -346.13 | -203.78 | -267.21 |
Change in Accounts Payable | -3,837 | -3,392 | 1,781 | 1,304 | 378.1 | 213.8 |
Change in Other Net Operating Assets | -66.29 | -70.84 | -28.38 | -12.03 | -1.02 | -83.61 |
Operating Cash Flow | 1,817 | 1,507 | 396.21 | -773.41 | 132.55 | -61.76 |
Operating Cash Flow Growth | 89.40% | 280.47% | - | - | - | - |
Capital Expenditures | -310.3 | -278.23 | -702.92 | -936.14 | -1,270 | -1,143 |
Sale of Property, Plant & Equipment | 7.26 | 6.96 | 3.6 | 2.25 | - | - |
Investing Cash Flow | -303.04 | -271.27 | -699.32 | -933.89 | -1,270 | -1,143 |
Short-Term Debt Issued | - | - | - | - | - | 913.16 |
Long-Term Debt Issued | - | - | - | 40.64 | - | - |
Total Debt Issued | - | - | - | 40.64 | 2,243 | 913.16 |
Long-Term Debt Repaid | - | -143.27 | -61.85 | -214.58 | - | -537.12 |
Total Debt Repaid | -248.35 | -143.27 | -61.85 | -214.58 | -1,888 | -537.12 |
Net Debt Issued (Repaid) | -248.35 | -143.27 | -61.85 | -173.95 | 354.58 | 376.04 |
Issuance of Common Stock | - | - | - | 3,710 | - | - |
Common Dividends Paid | - | - | - | - | -106.35 | -132.94 |
Other Financing Activities | -1,421 | -1,316 | -866.79 | -816.02 | -358.37 | -239.52 |
Financing Cash Flow | -1,669 | -1,459 | -928.64 | 2,721 | -110.15 | 3.58 |
Foreign Exchange Rate Adjustments | -166.61 | -167.17 | 923.58 | 791.25 | -3.43 | 0 |
Net Cash Flow | -321.8 | -389.81 | -308.16 | 1,804 | -1,251 | -1,201 |
Free Cash Flow | 1,507 | 1,229 | -306.71 | -1,710 | -1,137 | -1,205 |
Free Cash Flow Growth | 656.51% | - | - | - | - | - |
Free Cash Flow Margin | 19.04% | 16.68% | -6.84% | -77.37% | -38.95% | -44.57% |
Free Cash Flow Per Share | 0.35 | 0.29 | -0.07 | -0.40 | -0.60 | -0.63 |
Cash Interest Paid | 1,427 | 1,322 | 873.32 | 667.95 | 300 | 181.77 |
Cash Income Tax Paid | 38 | 38 | 12.49 | 125.84 | 53.76 | 31.81 |
Levered Free Cash Flow | -4,802 | -4,776 | 914.96 | 722.07 | - | -1,309 |
Unlevered Free Cash Flow | -3,910 | -3,950 | 1,461 | 1,140 | - | -1,195 |
Change in Working Capital | -5,029 | -5,215 | 1,178 | 1,493 | 35.59 | -143.94 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.